Index Banner
LUX CAPITAL
The Lux Bio + Tech Index

LUXBT

Index Performance

-15.78%
LUXBT
-5.26%
IBB
+6.88%
SPY
Aug 27, 2024Sep 5, 2024Sep 13, 2024Sep 24, 2024Oct 2, 2024Oct 10, 2024Oct 18, 2024Oct 28, 2024Nov 5, 2024Nov 13, 2024Nov 25, 2024-30%-20%-10%0%10%

Overview

Description

Developed by Lux Capital, the Lux Bio + Tech Index™ is a secular investment theme that covers companies innovating to further the molecular understanding of the "omics stack" to companies building "operating systems" for the future of drug discovery and ultimately even drug development. Over time these companies have transformed from radical, even heretical, ideas to undeniable technical, scientific, and clinical proof points. The last decade has ushered in an unparalleled understanding of the molecular basis of biology, enabled by emergent tool kits to engineer and perturb biology, ultimately increasing the velocity of discovery. Today, Moore's Law-like cost curves exist along many axes in biotech and have given rise to an era of precise, high fidelity, large scale, highly reproducible, and increasingly automated biological and chemical experimentation and discovery. The modern scientist-entrepreneur not only sits at the wetbench but also has proficiency to deconvolute high dimensional and historically unmanageable data with GPUs, the cloud, and the array of advances from machine learning and deep learning.

Full methodology
  • TickerLUXBT
  • Inception Date04/23/2021
  • WeightingEqual
  • # of holdings44
What's inside?
Sectors
  • Health Technology
    94.72%
  • Technology Services
    5.27%

Holdings

All holdings as of November 25, 2024
CSV download
Recursion Pharmaceuticals, Inc. (RXRX)4.62%$2.29B147.62%37.97%23.37
Evotec SE (EVO)3.31%$1.73B-4.87%9.89%1.76
Schrödinger, Inc. (SDGR)2.96%$1.42B-17.10%50.24%5.55
Revolution Medicines, Inc. (RVMD)2.82%$9.67BN/AN/A8,225.88
Nuvation Bio, Inc. (NUVB)2.79%$972.68MN/A-130.67%40.94
AbCellera Biologics, Inc. (ABCL)2.74%$871.33M-1.39%-488.52%5.15
Beam Therapeutics, Inc. (BEAM)2.65%$2.21B-17.01%61.63%3.59
CRISPR Therapeutics AG (CRSP)2.58%$4.30BN/A-2,550.00%11.32
Roivant Sciences Ltd. (ROIV)2.54%$9.07B-87.94%94.77%28.46
Kymera Therapeutics, Inc. (KYMR)2.54%$3.05B-20.88%46.54%35.87
Erasca, Inc. (ERAS)2.53%$780.33MN/AN/AN/A
Janux Therapeutics, Inc. (JANX)2.52%$2.56B-82.56%-16.17%141.56
BridgeBio Pharma, Inc. (BBIO)2.50%$5.14B-33.22%32.80%28.17
Rapport Therapeutics, Inc. (RAPP)2.49%$816.75MN/AN/AN/A
Verve Therapeutics, Inc. (VERV)2.46%$447.87M120.24%74.45%-2.42
Adaptive Biotechnologies Corp. (ADPT)2.35%$823.49M22.46%58.81%4.15
Arvinas, Inc. (ARVN)2.34%$1.73B195.95%N/A4.07
Stoke Therapeutics, Inc. (STOK)2.32%$623.95M47.94%77.30%27.38
Certara, Inc. (CERT)2.32%$1.78B10.80%46.66%5.26
Third Harmonic Bio, Inc. (THRD)2.31%$560.53MN/AN/AN/A
BioNTech SE (BNTX)2.29%$28.71B40.41%85.63%3.23
Nurix Therapeutics, Inc. (NRIX)2.28%$1.55B-31.84%67.06%25.04
Vir Biotechnology, Inc. (VIR)2.23%$1.02B-9.81%-23.78%1.68
Prime Medicine, Inc. (PRME)2.20%$436.77MN/A-645.45%411.51
Alnylam Pharmaceuticals, Inc. (ALNY)2.18%$32.37B-33.26%82.85%16.86
Ionis Pharmaceuticals, Inc. (IONS)2.17%$5.60B-7.21%95.09%6.79
CG Oncology, Inc. (CGON)2.15%$2.30BN/A51.16%2,935.36
Nuvalent, Inc. (NUVL)2.12%$6.27BN/AN/AN/A
Dyne Therapeutics, Inc. (DYN)2.10%$3.00BN/AN/AN/A
Ultragenyx Pharmaceutical, Inc. (RARE)2.04%$4.35B42.27%78.65%10.71
BioAge Labs, Inc. (BIOA)2.02%$652.13MN/AN/AN/A
Alector, Inc. (ALEC)1.99%$387.81M68.43%85.72%0.52
Denali Therapeutics, Inc. (DNLI)1.99%$3.53B-100.00%N/AN/A
Intellia Therapeutics, Inc. (NTLA)1.91%$1.51B-24.02%71.38%35.26
SAGE Therapeutics, Inc. (SAGE)1.85%$322.99M337.08%55.54%-1.12
4D Molecular Therapeutics, Inc. (FDMT)1.78%$352.26M-99.99%-56,666.67%5.96
10X Genomics, Inc. (TXG)1.78%$1.64B-1.30%69.50%3.83
Fate Therapeutics, Inc. (FATE)1.75%$275.62M58.13%-49.87%15.93
Relay Therapeutics, Inc. (RLAY)1.73%$813.48M-100.00%N/A20.29
Regeneron Pharmaceuticals, Inc. (REGN)1.72%$81.00B10.65%83.53%8.31
Compass Pathways Plc (CMPS)1.71%$312.68MN/AN/AN/A
Moderna, Inc. (MRNA)1.69%$16.80B1.69%69.60%4.17
Sana Biotechnology, Inc. (SANA)1.36%$553.71MN/AN/AN/A
Tango Therapeutics, Inc. (TNGX)1.27%$408.19M8.15%94.64%13.37
Market data by FactSet